Clinical Trials in Arroyo Grande, United States
Locations / Arroyo Grande, United States
Delta Trials lists 224 clinical trials conducted in Arroyo Grande, United States, making it a notable site of clinical research activity. These trials addressing 1,067 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 13 trials in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Arroyo Grande research landscape.
224
Total Trials
1067
Conditions
13
Terminated since 2020
Browse by condition (1067 total)
- Stage iv lung cancer ajcc v8 12 trialsAll Stage iv lung cancer ajcc v8 trials
- Invasive breast carcinoma 11 trialsAll Invasive breast carcinoma trials
- All Anatomic stage ii breast cancer ajcc v8 trials
- All Recurrent lung non-small cell carcinoma trials
- Recurrent ovarian carcinoma 7 trialsAll Recurrent ovarian carcinoma trials
- Stage iiib lung cancer ajcc v8 7 trialsAll Stage iiib lung cancer ajcc v8 trials
- Malignant solid neoplasm 7 trialsAll Malignant solid neoplasm trials
- All Anatomic stage iii breast cancer ajcc v8 trials
- Melanoma 6 trialsAll Melanoma trials
- Stage iva lung cancer ajcc v8 6 trialsAll Stage iva lung cancer ajcc v8 trials
- Metastatic malignant solid neoplasm 6 trialsAll Metastatic malignant solid neoplasm trials
- All Anatomic stage iv breast cancer ajcc v8 trials
- Stage ivb lung cancer ajcc v8 6 trialsAll Stage ivb lung cancer ajcc v8 trials
- Her2/neu negative 6 trialsAll Her2/neu negative trials
- All Anatomic stage i breast cancer ajcc v8 trials
- Breast carcinoma 5 trialsAll Breast carcinoma trials
- Stage ivb prostate cancer ajcc v8 5 trialsAll Stage ivb prostate cancer ajcc v8 trials
- Unresectable melanoma 5 trialsAll Unresectable melanoma trials
- Stage iiia lung cancer ajcc v8 5 trialsAll Stage iiia lung cancer ajcc v8 trials
- Chronic lymphocytic leukemia 5 trialsAll Chronic lymphocytic leukemia trials